Video summary
Chronic tinnitus significantly diminishes the quality of life for millions worldwide, affecting sleep, concentration, and social interaction while increasing risks for anxiety and depression. To address this condition effectively, medical professionals rely on standardized tools like the Tinnitus Handicap Inventory (THI) to measure severity and determine treatment success; a meaningful improvement is generally defined as a score reduction between seven and eleven points. Current clinical guidelines from 2014 through 2025 emphasize non-invasive approaches such as educational counseling, cognitive behavioral therapy (CBT), sound-based therapies, hearing devices for those with hearing loss, and physical therapy for co-existing conditions like TMJ disorders.
Among these conventional treatments, CBT stands out as having the strongest evidence base, capable of reducing tinnitus impact by approximately eleven points on its own or up to fifteen points when combined with other methods compared to alternatives like Tinnitus Retraining Therapy. Its flexibility allows it to be delivered in various formats including online sessions, phone calls, and group settings without adverse effects, making it a superior choice over invasive procedures such as steroid injections into the eardrum or low-level laser therapy which guidelines specifically advise against due to lack of efficacy. While surgery remains necessary for specific conditions like vestibular schwannoma and cochlear implants can help hearing loss-related tinnitus, these options carry risks where benefits may diminish over time, whereas neuromodulation techniques currently face mixed evidence regarding their general recommendation despite some recent approvals in the United States.
The landscape of pharmacological treatment presents further challenges as no drugs have been specifically approved by major regulatory bodies like the US FDA or European medical associations for tinnitus relief; instead, millions of prescriptions annually involve off-label use of medications with uncertain efficacy such as benzodiazepines used to manage anxiety symptoms associated with the condition. Given that tinnitus is a long-term issue rather than an acute one, relying on short-term medication like benzodiazepines is unlikely to provide optimal solutions compared to established behavioral interventions. Additionally, numerous alternative treatments exist but currently lack sufficient evidence for either recommendation or rejection according to clinical guidelines, leaving patients with limited options beyond the conservative yet supportive strategies of counseling and cognitive restructuring that have proven most reliable in improving daily functioning despite weak overall evidence strength across all intervention categories.
Read the full video transcript
[music]
Because chronic tinitus is a condition
that negatively impacts the quality of
life for millions of people worldwide, a
safe and effective treatment has been
sought for millennia with medical
records dating back 5,000 years,
proposing treatments for a bewitched
ear.
The more bothersome the tinitus, the
greater the negative impacts on sleep
quality, concentration, and
conversational speech along with
potential increased risk of anxiety,
depression, and cognitive impairments.
So, what can be done to make tinitus
less bothersome? To answer this
question, we first need to know how
tinitus is measured. Survey style
measurement tools are used to assess the
severity of tenitus and to determine
what treatments actually improve
symptoms. The THI is frequently used in
clinical research and practice to
quantify tinitus related handicaps and
the complex functional and emotional
impacts.
The minimal clinically important
difference represents exactly that. The
smallest change in treatment outcome
deemed to make a meaningful difference.
For the THI score, a drop of about seven
points makes the cut, while a more
recent study estimated an 11 point
reduction is needed. So something in the
range of a 7 to 11 point drop we should
expect for a minimally effective
treatment. The scope of potential
treatment options is wide but not all
are supported by robust evidence.
Several clinical guidelines published
between 2014 and 2023 most often
recommended educational counseling
helping people better understand their
condition and cognitive behavioral
therapy also called CBT. A new 2025
guideline by the US Department of
Veterans Affairs and Department of
Defense also recommended these
approaches along with hearing devices
for those with impaired hearing,
soundbased therapy alone or combined
with CBT or educational counseling, and
physical therapy for those who have a
co- condition like TMJ.
Now, the clinical guidelines consider
the strength of the evidence weak but
supportive for these interventions. No
intervention was rated any higher.
Arguably CBT has some of the strongest
evidence as found in this Cochran
systematic review. CBT targets improving
thoughts, feelings, and behaviors
associated with tinitus and can reduce
the impact of tenitus on people's
quality of life, the equivalent of about
11 points on the THI index. Compared to
other treatments like tenitus retraining
therapy, which involves both counseling
and sound therapy, it may be superior by
about 15 points.
But the evidence was less certain.
CBT is also flexible. It seems to work
whether delivered in person, online, by
phone, individually, or in groups.
The additional plus to CBT is that has
few or no adverse effects.
Which can't be said for more invasive
treatments like injecting cortical
steroids into the eardrum, which
clinical guidelines specifically
recommend against along with low-level
laser therapy. Now, not all invasive
treatments are bad. If someone has
another ear condition that needs to be
treated, like vestibular schwanoma, a
benign tumor in the ear that can damage
nearby structures, surgery may be
warranted.
Similarly, if hearing loss is impacting
someone's ability to communicate, then
something like a cocular implant may
make sense, which can substantially
improve tinitus in those patients,
though the benefit may fade over time.
Another proposed strategy is neurom
modulation which uses electrical or
electromagnetic stimulation to influence
neurons in the auditory pathway as well
as in emotional and attention centers of
the brain. So far clinical guidelines
have considered there to be insufficient
evidence to make a general
recommendation for or against neurom
modulation.
But the evidence for one type has made
the cut both in the US and Europe linear
biodal treatment. Due to positive
efficacy and safety outcomes, the US
Food and Drug Administration approved
its use for tenitus in March 2023.
A series of large randomized clinical
studies showed biodal neurom modulation
combining sound and tongue stimulation
significantly reduce tenitus symptoms
for up to 12 months after treatment.
The caveat being that not all
participants improved and there doesn't
appear to be any placeboc controlled
studies with sham devices to prove they
actually work for anybody, but certainly
worth a try. Are there any pills people
can pop to help? While over 4 million
prescriptions are written every year in
Europe and the US for tinitus relief,
all are off label prescriptions from a
wide variety of drugs with uncertain
efficacy.
Among the most prescribed medicines for
tinitus are anxolytics such as
bzzoazipines. Despite no robust evidence
from clinical trials supporting their
use given tinitus is a long-term
condition, the use of short-term
medication like bzzoazipines is unlikely
to be the best option. No drugs have
been approved by the US FDA or European
medical association specifically for
treating tinitus. guidelines are by
definition conservative as there is
generally more evidence for established
treatments than newer approaches.
The clinical guidelines also had a long
list of potential alternative treatments
with insufficient evidence to recommend
for or against.
What evidence do we have for alternative
treatments? I'll cover that next.